# Merit Cudkowicz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/merit-cudkowicz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,278 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 93 |
| i10-index | 257 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5044584675 |
| ORCID iD | https://orcid.org/0000-0002-7075-1681 |
| Works | 428 |

## Researcher papers

- [Gait variability and basal ganglia disorders: Stride‐to‐stride variations of gait cycle timing in parkinson's disease and Huntington's disease](https://scholariq.org/papers/gait-variability-and-basal-ganglia-disorders-stride-to-stride-variations-of-gait/)
- [Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS](https://scholariq.org/papers/trial-of-antisense-oligonucleotide-tofersen-for-i-sod1-i-als/)
- [Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS](https://scholariq.org/papers/phase-1-2-trial-of-antisense-oligonucleotide-tofersen-for-i-sod1-i-als/)
- [Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis](https://scholariq.org/papers/trial-of-sodium-phenylbutyrate-taurursodiol-for-amyotrophic-lateral-sclerosis/)
- [A clinical trial of creatine in ALS](https://scholariq.org/papers/a-clinical-trial-of-creatine-in-als/)
- [The PRO-ACT database](https://scholariq.org/papers/the-pro-act-database/)
- [Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis](https://scholariq.org/papers/phase-2-trial-of-ibudilast-in-progressive-multiple-sclerosis/)
- [Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/safety-and-efficacy-of-ceftriaxone-for-amyotrophic-lateral-sclerosis-a-multi/)
- [A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis](https://scholariq.org/papers/a-randomized-placebo-controlled-trial-of-topiramate-in-amyotrophic-lateral/)
- [Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>](https://scholariq.org/papers/long-term-survival-of-participants-in-the-scp-centaur-scp-trial-of-sodium/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.